Delivery Order SPE2DB20D9214-SPE2DB24FD4SL
Award Date 3/11/24
Potential Completion Date 4/1/24
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGE/ML. The contract has a potential value of $21,663.60 and a completion date of January 24, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drugs to the federal government, primarily the Department of Defense, under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of XOLAIR 150 MG/ML syringes. The total ceiling value of the order is $77,370.00, with an ultimate completion date of September 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML syringes. The order has a potential value of $27,853.20 and a completion date of January 30, 2024. This order is placed against an existing indefinite delivery contract with DMS Pharmaceutical Group to provide a variety of pharmaceutical and medical supplies to support military treatment facilities globally. DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of XOLAIR 150 MG/ML syringes. This $9,284.40 contract has a completion date of May 24, 2024 and is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with DLA for pharmaceutical supplies supporting military health facilities. This contract has no set-aside designation. DMS Pharmaceutical Group is a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product XOLAIR 150 MG/ML SYRINGE. The contract has a potential value of $14,700.32 and a completion date of March 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that supplies a wide range of branded and generic pharmaceuticals to U.S. government agencies,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract for $18,568.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Xolair 150 mg/ml syringes. This order is part of a larger indefinite delivery contract, number 4600082013, held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, with a ceiling value of up to $4,999,999 through 2025. The contract does not have a set-aside designation. DMS Pharmaceutical Group is a...
- This firm-fixed-price delivery order for $9,284.40 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 MG/ML syringes. The order is part of a larger $4,999,999 indefinite delivery contract (SPE2DB) that enables DLA to issue delivery orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group is an experienced...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Xolair 150 mg/mL syringes. The delivery order, valued at $11,605.50, has a completion date of February 5, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) with DLA to supply pharmaceuticals and medical products to military treatment facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML syringes and has a performance period through May 2, 2024. This award is placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with DLA, valued at up to $4,999,999 through 2025. Under this broader contract vehicle, DMS Pharmaceutical Group...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $18,568.80, is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML pharmaceutical products. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the DLA, valued up to $4,999,999 through 2025, which enables the agency to procure a broad...